Literature DB >> 19853512

Monocytes and gammadelta T cells: close encounters in microbial infection.

Matthias Eberl1, Bernhard Moser.   

Abstract

gammadelta T cells comprise an evolutionarily conserved yet poorly understood subset of T cells. Numerous features place these unconventional lymphocytes at the branching point between antigen-presenting cells and natural killer cells of the innate immune system and major-histocompatibility-complex-restricted alphabeta T cells of the adaptive immune system. We propose a role for human Vgamma9/Vdelta2 T cells in the generation of monocyte-derived inflammatory dendritic cells during infection. Our model incorporates the peculiar innate-like specificity of Vgamma9/Vdelta2 T cells for the microbial metabolite (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMB-PP), co-recruitment of monocytes and Vgamma9/Vdelta2 T cells to sites of infection, and their crosstalk, with profound consequences for the initiation of antigen-specific alphabeta T-cell responses. Vgamma9/Vdelta2 T cells act thus as a cellular switch between innate and adaptive defence mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19853512     DOI: 10.1016/j.it.2009.09.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  22 in total

Review 1.  γδ T-APCs: a novel tool for immunotherapy?

Authors:  Bernhard Moser; Matthias Eberl
Journal:  Cell Mol Life Sci       Date:  2011-05-15       Impact factor: 9.261

2.  Activated gammadelta T cells promote the activation of uveitogenic T cells and exacerbate EAU development.

Authors:  Hong Nian; Hui Shao; Rebecca L O'Brien; Willi K Born; Henry J Kaplan; Deming Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

3.  Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.

Authors:  Sil Park; Keiichi Kanayama; Kawaljit Kaur; Han-Ching Helen Tseng; Sina Banankhah; Davood Talebi Quje; James W Sayre; Anahid Jewett; Ichiro Nishimura
Journal:  J Biol Chem       Date:  2015-05-26       Impact factor: 5.157

Review 4.  Six-of-the-best: unique contributions of γδ T cells to immunology.

Authors:  Pierre Vantourout; Adrian Hayday
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

Review 5.  Metabolic pathways in immune cell activation and quiescence.

Authors:  Erika L Pearce; Edward J Pearce
Journal:  Immunity       Date:  2013-04-18       Impact factor: 31.745

Review 6.  γδ T cells in rheumatic diseases: from fundamental mechanisms to autoimmunity.

Authors:  Cuong Thach Nguyen; Emanual Maverakis; Matthias Eberl; Iannis E Adamopoulos
Journal:  Semin Immunopathol       Date:  2019-09-10       Impact factor: 9.623

7.  Transient atypical monocytosis after α/β T-cell-depleted haploidentical hematopoietic stem cell transplantation.

Authors:  Angela Liou; John Van Arnam; Vinodh Pillai; Alix E Seif; Sarah K Tasian; Charles A Phillips
Journal:  Pediatr Blood Cancer       Date:  2019-12-22       Impact factor: 3.167

8.  Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection.

Authors:  Martin S Davey; Chan-Yu Lin; Gareth W Roberts; Sinéad Heuston; Amanda C Brown; James A Chess; Mark A Toleman; Cormac G M Gahan; Colin Hill; Tanya Parish; John D Williams; Simon J Davies; David W Johnson; Nicholas Topley; Bernhard Moser; Matthias Eberl
Journal:  PLoS Pathog       Date:  2011-05-12       Impact factor: 6.823

9.  Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells.

Authors:  Martin S Davey; Matt P Morgan; Anna Rita Liuzzi; Christopher J Tyler; Mohd Wajid A Khan; Tamas Szakmany; Judith E Hall; Bernhard Moser; Matthias Eberl
Journal:  J Immunol       Date:  2014-08-27       Impact factor: 5.422

10.  Increased cholesterol content in gammadelta (γδ) T lymphocytes differentially regulates their activation.

Authors:  Hsin-Yuan Cheng; Runpei Wu; Abraham K Gebre; Richard N Hanna; Dan J Smith; John S Parks; Klaus Ley; Catherine C Hedrick
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.